Amedeo Smart

Free Medical Literature Service


 

Amedeo

Valvular Heart Disease

  Free Subscription

Articles published in
Eur Heart J
    March 2024
  1. CREA F
    Mitral, aortic, and tricuspid valve disease: new light shed on mechanisms, risk stratification, and treatment optimization.
    Eur Heart J. 2024;45:857-860.
    >> Share

  2. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
    Great debate: symptomatic moderate aortic stenosis should undergo intervention.
    Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
    >> Share

  3. MARTINSSON A, Rasalingam R, Jeppsson A
    Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population?
    Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093.
    >> Share

  4. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    >> Share

  5. MURARU D, Badano LP, Hahn RT, Lang RM, et al
    Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
    Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
    >> Share

  6. MEHILLI J
    Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
    Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
    >> Share

  7. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
    Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
    Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
    >> Share

  8. MCGREGOR M, Bews H, Jassal DS
    Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place.
    Eur Heart J. 2024 Mar 4:ehae115. doi: 10.1093.
    >> Share

  9. MAISANO F, Hahn R, Sorajja P, Praz F, et al
    Transcatheter treatment of the tricuspid valve: current status and perspectives.
    Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
    >> Share

    February 2024
  10. WU J, Zafar MA, Elefteriades JA
    Decision-making in aortic disease.
    Eur Heart J. 2024;45:633-634.
    >> Share

  11. MESSIKA-ZEITOUN D, Iung B, Baumgartner H
    The year in cardiovascular medicine 2023: the top 10 papers in valvular heart disease.
    Eur Heart J. 2024 Feb 21:ehae090. doi: 10.1093.
    >> Share

  12. LURZ P, Kresoja KP
    Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
    Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
    >> Share

  13. LUDWIG S, Granada JF
    Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward.
    Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093.
    >> Share

  14. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    >> Share

  15. CREA F
    The dark side of arrhythmia treatment: iatrogenic tricuspid regurgitation and drug toxicity.
    Eur Heart J. 2024;45:317-320.
    >> Share

    January 2024
  16. THORNTON GD, Vassiliou VS, Musa TA, Aziminia N, et al
    Myocardial Scar and Remodelling Predict Long-Term Mortality in Severe Aortic Stenosis Beyond 10 Years.
    Eur Heart J. 2024 Jan 25:ehae067. doi: 10.1093.
    >> Share

  17. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    >> Share

  18. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    >> Share

  19. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
    Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
    Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
    >> Share

  20. NAKAMURA K, Taniguchi T, Furukawa Y
    Haemolytic anaemia after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 18:ehae010. doi: 10.1093.
    >> Share

  21. LI Z, Zhang H, Lin S
    Functionally bicuspid aortic valve leads to myocardial ischaemia.
    Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
    >> Share

  22. LONG X, Deng S, Liu W, Bu J, et al
    Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study.
    Eur Heart J. 2024;45:233-235.
    >> Share

  23. HASCOET S, Bentham JR, Giugno L, Betrian-Blasco P, et al
    Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
    Eur Heart J. 2024;45:198-210.
    >> Share

  24. BENFARI G, Essayagh B, Michelena HI, Ye Z, et al
    Severe aortic stenosis: secular trends of incidence and outcomes.
    Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093.
    >> Share

  25. KADDOURA R, Al-Hijji M
    The evolution of transcatheter valvular interventions: current evidence.
    Eur Heart J. 2024;45:10-14.
    >> Share

    December 2023
  26. ALLOUBA M, Walsh R, Afify A, Hosny M, et al
    Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:5146-5158.
    >> Share

  27. INGLES J, MacArthur DG
    The moral and practical urgency of increasing diversity in genomics.
    Eur Heart J. 2023;44:5157-5159.
    >> Share

  28. ANDREAS M, Burri H, Praz F, Soliman O, et al
    Tricuspid valve disease and cardiac implantable electronic devices.
    Eur Heart J. 2023 Dec 14:ehad783. doi: 10.1093.
    >> Share

  29. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    >> Share

  30. GRANI C
    Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:4793-4795.
    >> Share

  31. WANG J, Yang S, Ma X, Zhao K, et al
    Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
    Eur Heart J. 2023;44:4781-4792.
    >> Share

    November 2023
  32. VERGALLO R, Volpe M
    Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients.
    Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093.
    >> Share

  33. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    >> Share

  34. BRAUNWALD E, Saberi S, Abraham TP, Elliott PM, et al
    Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:4622-4633.
    >> Share

  35. TOMII D, Praz F, Windecker S
    Guideline directed medical therapy in patients with heart failure undergoing transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
    Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093.
    >> Share

  36. CREA F
    Hot topics in valvular heart disease: tricuspid regurgitation, bicuspid aortic valve, artificial intelligence for aortic stenosis, and aortic aneurysm.
    Eur Heart J. 2023;44:4493-4496.
    >> Share

  37. PATEL KP, Baumbach A
    Timing treatment for tricuspid regurgitation.
    Eur Heart J. 2023 Nov 9:ehad768. doi: 10.1093.
    >> Share

  38. WERT L, Falk V, Potapov EV
    Severe aortic regurgitation after short-term treatment with microaxial left ventricular assist device in the transaxillary approach.
    Eur Heart J. 2023 Nov 9:ehad750. doi: 10.1093.
    >> Share

  39. IDHREES M, Kumar A, Velayudhan B
    'Paravalvular leak' after Bentall's procedure, yet not a paravalvular leak.
    Eur Heart J. 2023;44:4392.
    >> Share

  40. KODALI S, Hahn RT, Makkar R, Makar M, et al
    Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.
    Eur Heart J. 2023 Nov 1:ehad667. doi: 10.1093.
    >> Share

    October 2023
  41. HARARI E, Landes U
    Post-Transcatheter Aortic Valve Implantation paravalvular leak: multiple aetiologies and no panacea.
    Eur Heart J. 2023 Oct 28:ehad696. doi: 10.1093.
    >> Share

  42. KALINCZUK L, Skotarczak W, Sondergaard L, Mintz GS, et al
    Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement.
    Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093.
    >> Share

  43. DE BACKER J, Prakash SK
    Refining the course: long-term outcome in patients with bicuspid aortic valve.
    Eur Heart J. 2023 Oct 4:ehad621. doi: 10.1093.
    >> Share

  44. FARJAT-PASOS JI, Dumont E, Paradis JM
    Optimizing transcatheter mitral valve replacement with direct, continuous transvalvular haemodynamic evaluation: first-in-man.
    Eur Heart J. 2023 Oct 4:ehad603. doi: 10.1093.
    >> Share

  45. HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al
    Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
    Eur Heart J. 2023 Oct 4:ehad653. doi: 10.1093.
    >> Share

  46. WEISSLER-SNIR A, Rakowski H, Meyer M
    Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?
    Eur Heart J. 2023;44:3655-3657.
    >> Share

  47. DEVRIES JH, Irs A, Hillege HL
    The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.
    Eur Heart J. 2023;44:3492-3494.
    >> Share

    September 2023
  48. CHHABRA ST, Takkar A, Arya RC
    An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'.
    Eur Heart J. 2023 Sep 29:ehad652. doi: 10.1093.
    >> Share

  49. BEYGUI F, Guillemot V, Saloux E
    Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
    Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
    >> Share

  50. MOORE JP, Aboulhosn JA, Khairy P
    Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot.
    Eur Heart J. 2023;44:3228-3230.
    >> Share

  51. CREA F
    TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
    Eur Heart J. 2023;44:3105-3109.
    >> Share

  52. FENG S, Wu F, Pan X
    Computational fluid dynamics as a novel method to predict haemodynamic changes and guide transcatheter edge-to-edge repair.
    Eur Heart J. 2023;44:3199.
    >> Share

    August 2023
  53. VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al
    Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.
    Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093.
    >> Share

  54. DREYFUS J, Galloo X, Taramasso M, Heitzinger G, et al
    TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.
    Eur Heart J. 2023 Aug 25:ehad585. doi: 10.1093.
    >> Share

  55. YANG LT, Ye Z, Wajih Ullah M, Maleszewski JJ, et al
    Bicuspid aortic valve: long-term morbidity and mortality.
    Eur Heart J. 2023 Aug 23:ehad477. doi: 10.1093.
    >> Share

  56. HOLSTE G, Oikonomou EK, Mortazavi BJ, Coppi A, et al
    Severe aortic stenosis detection by deep learning applied to echocardiography.
    Eur Heart J. 2023 Aug 23:ehad456. doi: 10.1093.
    >> Share

  57. VAN DISSEL AC, Opotowsky AR, Burchill LJ, Aboulhosn J, et al
    End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study.
    Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093.
    >> Share

  58. PRENDERGAST BD, Patterson T, Redwood S
    Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
    Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
    >> Share

  59. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
    Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
    Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
    >> Share

  60. AL ZAIDI M, Nickenig G, Zimmer S
    Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
    Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
    >> Share

  61. EIROS R, Gallego-Delgado M, Villacorta E
    Unravelling an hypertrophic myocardiopathy.
    Eur Heart J. 2023;44:2788.
    >> Share

    July 2023
  62. IUNG B, Pierard L, Magne J, Messika-Zeitoun D, et al
    Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement.
    Eur Heart J. 2023 Jul 28:ehad355. doi: 10.1093.
    >> Share

  63. WALDSCHMIDT L, Seiffert M
    Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?
    Eur Heart J. 2023 Jul 5:ehad277. doi: 10.1093.
    >> Share

  64. GOLTSTEIN LCMJ, Rooijakkers MJP, Hoeks M, Li WWL, et al
    Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis.
    Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093.
    >> Share

  65. LORENZATTI D, Pina P, Slipczuk L
    Cardiovascular computed tomography in the evaluation of post-TAVI prosthesis dysfunction: the thin line between hypo attenuated leaflet thickening and clinical valve thrombosis.
    Eur Heart J. 2023;44:2350.
    >> Share

    June 2023
  66. NOTENBOOM ML, Schuermans A, Etnel JRG, Veen KM, et al
    Paediatric aortic valve replacement: a meta-analysis and microsimulation study.
    Eur Heart J. 2023 Jun 27:ehad370. doi: 10.1093.
    >> Share

  67. GOEL K, Shah P, Jones BM, Korngold E, et al
    Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
    >> Share


  68. Corrigendum to: MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Jun 21:ehad407. doi: 10.1093.
    >> Share

  69. TAKANO R, Tsuji A, Ogo T
    A beaded ductus arteriosus aneurysm in tetralogy of Fallot with pulmonary atresia after palliative surgery.
    Eur Heart J. 2023 Jun 17:ehad402. doi: 10.1093.
    >> Share

  70. PEDICINO D, Vergallo R
    Long-lasting effects of transcatheter repair of secondary mitral regurgitation: the latest lesson from COAPT trial.
    Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093.
    >> Share

  71. BRAY JJH, Freer R, Pitcher A, Kharbanda R, et al
    Family screening for bicuspid aortic valve and aortic dilatation: a meta-analysis.
    Eur Heart J. 2023 Jun 8:ehad320. doi: 10.1093.
    >> Share

  72. EVANGELISTA A, Michelena HI
    Family screening for bicuspid aortic valve: indicated, but easy to implement?
    Eur Heart J. 2023 Jun 8:ehad057. doi: 10.1093.
    >> Share

  73. CREA F
    Understanding aortic stenosis: advances in the identification of actionable pharmacological targets.
    Eur Heart J. 2023;44:1847-1850.
    >> Share

    May 2023
  74. LORENZINI M, Elliott PM
    Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?
    Eur Heart J. 2023;44:1519-1521.
    >> Share

  75. JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
    Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
    Eur Heart J. 2023;44:1530-1540.
    >> Share

    April 2023
  76. BUTCHER SC, Essayagh B, Enriquez-Sarano M
    Rescue surgery for degenerative mitral regurgitation should be recognized for what it is: indispensable but imperfect.
    Eur Heart J. 2023 Apr 28:ehad242. doi: 10.1093.
    >> Share

  77. DANDEL M
    Degenerative mitral regurgitation: improving clinical decision-making and risk stratification before valve surgery or trans-catheter repair.
    Eur Heart J. 2023 Apr 28:ehad216. doi: 10.1093.
    >> Share

  78. LI Y, He Q, Xie M
    A rare case of papillary muscle rupture caused by percutaneous balloon mitral valvuloplasty.
    Eur Heart J. 2023 Apr 26:ehad254. doi: 10.1093.
    >> Share

  79. LEE J, Kim JS, Shim CY
    MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
    >> Share

  80. PEDICINO D, Vergallo R
    Transcatheter repair for severe tricuspid regurgitation: are we going in the right direction?
    Eur Heart J. 2023 Apr 22:ehad219. doi: 10.1093.
    >> Share

  81. ORRINGER CE
    C-reactive protein in people with high lipoprotein a: a partner in crime or an innocent bystander?
    Eur Heart J. 2023;44:1461-1463.
    >> Share

  82. THERIAULT S, Mathieu P, Bosse Y
    The journey towards identification of actionable molecular pathways in calcific aortic valve stenosis.
    Eur Heart J. 2023 Apr 12:ehad134. doi: 10.1093.
    >> Share

  83. CHEN HY, Dina C, Small AM, Shaffer CM, et al
    Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study.
    Eur Heart J. 2023 Apr 11:ehad142. doi: 10.1093.
    >> Share

  84. SEQUEIRA V, Batzner A, Maack C
    Targeting mitochondria in hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:1186-1188.
    >> Share

  85. NOLLET EE, Duursma I, Rozenbaum A, Eggelbusch M, et al
    Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration.
    Eur Heart J. 2023;44:1170-1185.
    >> Share

    March 2023
  86. KAGASE A, Yamamoto M, Tokuda T
    Successful bailout clipping for rare complication of anterior mitral leaflet dissection during transcatheter edge-to-edge mitral valve repair.
    Eur Heart J. 2023 Mar 29:ehad163. doi: 10.1093.
    >> Share

  87. XIE Z, Zhu H
    A rare case of mitral regurgitation caused by primary aldosteronism.
    Eur Heart J. 2023 Mar 29:ehad180. doi: 10.1093.
    >> Share

  88. CHEN YH, Chang HH, Leu HB
    Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration.
    Eur Heart J. 2023 Mar 25:ehad164. doi: 10.1093.
    >> Share

  89. MAS-PEIRO S, Abplanalp WT, Rasper T, Berkowitsch A, et al
    Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement.
    Eur Heart J. 2023 Mar 18:ehad093. doi: 10.1093.
    >> Share

  90. CHORIN E, Topilsky Y
    The synergy between tricuspid regurgitation and machine learning.
    Eur Heart J. 2023 Mar 17:ehad140. doi: 10.1093.
    >> Share

  91. RAO VN, Giczewska A, Chiswell K, Felker GM, et al
    Long-term outcomes of phenoclusters in severe tricuspid regurgitation.
    Eur Heart J. 2023 Mar 16:ehad133. doi: 10.1093.
    >> Share

  92. MESSIKA-ZEITOUN D, Baumgartner H, Burwash IG, Vahanian A, et al
    Unmet needs in valvular heart disease.
    Eur Heart J. 2023 Mar 16:ehad121. doi: 10.1093.
    >> Share

  93. CHUNG CJ, Otto CM
    Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation.
    Eur Heart J. 2023 Mar 9:ehad151. doi: 10.1093.
    >> Share

  94. LANDES U, Hochstadt A, Manevich L, Webb JG, et al
    Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications.
    Eur Heart J. 2023 Mar 8:ehad146. doi: 10.1093.
    >> Share

  95. CREA F
    Spotlight on aortic stenosis and dissection: mechanisms, management, and new therapeutic targets.
    Eur Heart J. 2023;44:783-787.
    >> Share

  96. RODES-CABAU J, Nuche J
    Are contemporary TAVI results influenced by hospital volume?
    Eur Heart J. 2023;44:868-870.
    >> Share

  97. CHEN J, Yang Y, Wei L
    One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation.
    Eur Heart J. 2023 Mar 3:ehad094. doi: 10.1093.
    >> Share

  98. KEMALOGLU OZ T, Badano LP
    Can three-dimensional echocardiography change the game for the pulmonary valve?
    Eur Heart J. 2023;44:703-705.
    >> Share

    February 2023
  99. THOMAS PE, Vedel-Krogh S, Kamstrup PR, Nordestgaard BG, et al
    Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein.
    Eur Heart J. 2023 Feb 21:ehad055. doi: 10.1093.
    >> Share

  100. CHEN CB, Jarrett H, Goldman SM
    Candida endocarditis in a transcatheter aortic valve.
    Eur Heart J. 2023 Feb 13:ehad070. doi: 10.1093.
    >> Share

  101. IUNG B, Suc G
    Advances in risk stratification of asymptomatic mitral regurgitation. The quest for optimal timing of surgery continues.
    Eur Heart J. 2023 Feb 8:ehad040. doi: 10.1093.
    >> Share

    January 2023

  102. Corrigendum to: Dual versus single antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis.
    Eur Heart J. 2023 Jan 31:ehad047. doi: 10.1093.
    >> Share

  103. ZHANG T, Yang X, Song J, Shi Y, et al
    Emergent transcatheter aortic valve implantation combined with enterectomy for acute decompensated heart failure caused by severe aortic stenosis and strangulated femoral hernia.
    Eur Heart J. 2023 Jan 26:ehad007. doi: 10.1093.
    >> Share

  104. BUTCHER SC, Essayagh B, Steyerberg EW, Benfari G, et al
    Factors influencing post-surgical survival in degenerative mitral regurgitation.
    Eur Heart J. 2023 Jan 26:ehad004. doi: 10.1093.
    >> Share

  105. MARTIN M, Motta SE, Emmert MY
    Have we found the missing link between inflammation, fibrosis, and calcification in calcific aortic valve disease?
    Eur Heart J. 2023 Jan 23:ehac787. doi: 10.1093.
    >> Share

  106. GABRA B, Anavekar NS, Haaf P
    Hypertrophic cardiomyopathy and left ventricular non-compaction cardiomyopathy: two in one.
    Eur Heart J. 2023;44:327.
    >> Share

  107. IQBAL F, Schlotter F, Becker-Greene D, Lupieri A, et al
    Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity.
    Eur Heart J. 2023 Jan 20:ehac818. doi: 10.1093.
    >> Share

  108. AHMAD Y, Howard JP, Arnold AD, Madhavan MV, et al
    Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials.
    Eur Heart J. 2023 Jan 20:ehac642. doi: 10.1093.
    >> Share

  109. PILGRIM T, Siontis GCM, Windecker S
    Transcatheter aortic valve implantation: a blueprint for evidence-based evaluation of technological innovation.
    Eur Heart J. 2023 Jan 20:ehac635. doi: 10.1093.
    >> Share

  110. LEE G, Chikwe J, Milojevic M, Wijeysundera HC, et al
    ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis.
    Eur Heart J. 2023 Jan 12:ehac803. doi: 10.1093.
    >> Share

  111. MIYOSHI T, Izutani H, Yamaguchi O
    Pathologic findings of aortic valve leaflet injury via IMPELLA insertion.
    Eur Heart J. 2023 Jan 12:ehac806. doi: 10.1093.
    >> Share

  112. CHIETERA F, Saia F, Palmerini T
    Post-traumatic acute aortic regurgitation due to cusp rupture in non-calcific bicuspid valve treated with ballon-expandable transcatheter heart valve.
    Eur Heart J. 2023 Jan 12:ehac805. doi: 10.1093.
    >> Share

  113. KAISER Y, Labrecque J, Stroes ESG, Boekholdt SM, et al
    Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias? Reply.
    Eur Heart J. 2023 Jan 4:ehac742. doi: 10.1093.
    >> Share

  114. ENRIQUEZ-SARANO M, Grapsa J
    Valvular heart diseases in women: facts vs. incantations.
    Eur Heart J. 2023 Jan 4:ehac774. doi: 10.1093.
    >> Share

  115. LEVIN MG, Damrauer SM
    Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias?
    Eur Heart J. 2023 Jan 4:ehac638. doi: 10.1093.
    >> Share

  116. BAUMGARTNER H, Iung B, Messika-Zeitoun D
    The year in cardiovascular medicine 2022: the top 10 papers in valvular heart disease.
    Eur Heart J. 2023 Jan 2:ehac777. doi: 10.1093.
    >> Share

    December 2022

  117. Erratum to: Transfemoral aortic valve implantation: procedural hospital volume and mortality in Germany.
    Eur Heart J. 2022 Dec 22:ehac775. doi: 10.1093.
    >> Share

  118. BESTEHORN K, Bestehorn M, Zahn R, Perings C, et al
    Transfemoral aortic valve implantation: procedural hospital volume and mortality in Germany.
    Eur Heart J. 2022 Dec 2:ehac698. doi: 10.1093.
    >> Share

    November 2022
  119. SCOTTI A, Coisne A, Taramasso M, Granada JF, et al
    Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation.
    Eur Heart J. 2022 Nov 29:ehac735. doi: 10.1093.
    >> Share

  120. HUANG X, Sung SH, Su M, Wang Y, et al
    One stone hits two birds: transcatheter mitral valve edge-to-edge repair for hypertrophic obstructive cardiomyopathy and severe mitral regurgitation.
    Eur Heart J. 2022 Nov 25:ehac677. doi: 10.1093.
    >> Share

  121. GESKE JB, Stephens EH, Dearani JA
    Hypertrophic cardiomyopathy with extreme outflow tract obstruction.
    Eur Heart J. 2022;43:4518.
    >> Share

    October 2022
  122. MAN JP, Bouma BJ, Schuuring MJ
    Fusion imaging in preoperative planning of mitral valve surgery to prevent injury of the left circumflex artery.
    Eur Heart J. 2022 Oct 22. pii: 6769829. doi: 10.1093.
    >> Share

  123. CREA F
    Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: an emerging therapeutic target.
    Eur Heart J. 2022;43:3815-3818.
    >> Share

    September 2022
  124. AJMONE MARSAN N, Delgado V, Shah DJ, Pellikka P, et al
    Valvular heart disease: shifting the focus to the myocardium.
    Eur Heart J. 2022 Sep 28. pii: 6724464. doi: 10.1093.
    >> Share

  125. TEN BERG J, Rocca B, Angiolillo DJ, Hayashida K, et al
    The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties.
    Eur Heart J. 2022 Sep 21. pii: 6708420. doi: 10.1093.
    >> Share

  126. XIA J, Xue Y, Ma X
    A rare case of native aortic valve thrombosis after radiofrequency ablation.
    Eur Heart J. 2022 Sep 16. pii: 6701788. doi: 10.1093.
    >> Share

  127. HAN Y
    Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement.
    Eur Heart J. 2022 Sep 14. pii: 6697004. doi: 10.1093.
    >> Share

    August 2022
  128. KRONENBERG F, Mora S, Stroes ESG, Ference BA, et al
    Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
    Eur Heart J. 2022 Aug 29. pii: 6670882. doi: 10.1093.
    >> Share

  129. ZHANG X, Wang H, Guo Y, Peng Y, et al
    Aortic root 'sink down' caused mitral stenosis after aortic valve replacement: a rare presentation of Bechet's disease.
    Eur Heart J. 2022 Aug 18. pii: 6670978. doi: 10.1093.
    >> Share

  130. KRONENBERG F
    Lipoprotein(a) and aortic valve stenosis: work in progress.
    Eur Heart J. 2022 Aug 18. pii: 6670979. doi: 10.1093.
    >> Share

  131. WENZEL P
    Thromboinflammation in cardiovascular disease: lessons learned for the management of hypertension, heart failure, and aortic valve stenosis.
    Eur Heart J. 2022 Aug 18. pii: 6671020. doi: 10.1093.
    >> Share


  132. Corrigendum to: Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 Aug 3. pii: 6653544. doi: 10.1093.
    >> Share

  133. CREA F
    Challenges in the management of aortic stenosis, multiple valve disease, culture-negative endocarditis, and cardiac surgery during pregnancy.
    Eur Heart J. 2022;43:2715-2719.
    >> Share

  134. HAHN RT, Pibarot P, Otto CM
    Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease.
    Eur Heart J. 2022;43:2767-2769.
    >> Share

  135. ANDREOTTI F, Massetti M, Ten Berg J
    Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS.
    Eur Heart J. 2022;43:2798-2800.
    >> Share

  136. ZHAO ZG, Chen F, Wei X, Feng Y, et al
    Transcatheter mitral valve implantation in severely calcified rheumatic mitral stenosis without annular calcification.
    Eur Heart J. 2022 Aug 1. pii: 6652910. doi: 10.1093.
    >> Share

    July 2022
  137. KAISER Y, van der Toorn JE, Singh SS, Zheng KH, et al
    Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification.
    Eur Heart J. 2022 Jul 23. pii: 6649081. doi: 10.1093.
    >> Share

  138. PARALE C, Ahmed AS, Bhardwaj A
    Isolated posterior mitral leaflet elongation-related dynamic left ventricular outflow obstruction.
    Eur Heart J. 2022;43:2713.
    >> Share

  139. BHARDWAJ A, Pillai AA, Balaguru S
    A case of hypoplastic posterior mitral leaflet-related severe mitral regurgitation associated with ostium secundum atrial septal defect.
    Eur Heart J. 2022 Jul 21. pii: 6647914. doi: 10.1093.
    >> Share

  140. BAJAJ A, Cuchel M
    From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?
    Eur Heart J. 2022 Jul 13. pii: 6641994. doi: 10.1093.
    >> Share

  141. BELANGER AM, Akioyamen LE, Ruel I, Hales L, et al
    Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century.
    Eur Heart J. 2022 Jul 1. pii: 6625868. doi: 10.1093.
    >> Share

    June 2022
  142. VERGALLO R, Volpe M
    The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis.
    Eur Heart J. 2022 Jun 25. pii: 6617779. doi: 10.1093.
    >> Share


  143. Corrigendum to: Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2022 Jun 18. pii: 6611060. doi: 10.1093.
    >> Share

  144. WEI X, Zhou M, Chen Y, Chen M, et al
    Paroxysmal massive mitral regurgitation.
    Eur Heart J. 2022 Jun 17. pii: 6609956. doi: 10.1093.
    >> Share

  145. HAN Y
    Current clinical data and experience of TAVR in China.
    Eur Heart J. 2022;43:2087-2088.
    >> Share

  146. BELLUSCHI I, Buzzatti N, Denti P, Maisano F, et al
    Transcatheter lithotripsy to facilitate post-dilatation of underexpanded aortic transcatheter heart valve.
    Eur Heart J. 2022;43:2081.
    >> Share


  147. Corrigendum to: Transcatheter repair of persistent tricuspid regurgitation after MitraClip with the TriCinch system: interventional valve treatment toward the surgical standard.
    Eur Heart J. 2022 Jun 1. pii: 6596482. doi: 10.1093.
    >> Share


  148. Corrigendum to: Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation.
    Eur Heart J. 2022 Jun 1. pii: 6596481. doi: 10.1093.
    >> Share

    May 2022

  149. Corrigendum to: The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
    Eur Heart J. 2022 May 19. pii: 6588540. doi: 10.1093.
    >> Share

  150. COLLET JP, Van Belle E, Thiele H, Berti S, et al
    Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
    >> Share

  151. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
    Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
    Eur Heart J. 2022;43:1884.
    >> Share

  152. GALIUTO L, Massetti M
    To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
    Eur Heart J. 2022;43:1792-1793.
    >> Share

  153. WILSON J, Muthumala A, Khanji MY
    Complete resolution of apical hypertrophy and fibrosis: the role of serial cardiovascular magnetic resonance tissue characterization to differentiate hypertrophic cardiomyopathy from myocarditis.
    Eur Heart J. 2022;43:1774.
    >> Share

  154. TRIBOUILLOY C, Bohbot Y, Kubala M, Ruschitzka F, et al
    Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2022 May 2. pii: 6576528. doi: 10.1093.
    >> Share

  155. CREA F
    Valvular heart disease: the quest for new pharmacological targets.
    Eur Heart J. 2022;43:1601-1604.
    >> Share

  156. BEDEIR K, Robichaux RP, Gleason TG
    Surgical whole valve embolization 15 years after implantation.
    Eur Heart J. 2022;43:1685.
    >> Share

  157. JANG SJ, Chen YH, Shen TC
    Pitfalls in recapture or repositioning of Evolut system using cusp overlap technique.
    Eur Heart J. 2022;43:1684.
    >> Share

    April 2022
  158. WINDECKER S, Okuno T, Unbehaun A, Mack M, et al
    Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
    Eur Heart J. 2022 Apr 25. pii: 6572863. doi: 10.1093.
    >> Share

  159. DAYAN V, Gomes WJ
    The new ESC/EACTS recommendations for transcatheter aortic valve implantation go too far.
    Eur Heart J. 2022 Apr 25. pii: 6572861. doi: 10.1093.
    >> Share

  160. THIELE H, Collet JP, Leon M, Mehran R, et al
    The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
    Eur Heart J. 2022 Apr 25. pii: 6572862. doi: 10.1093.
    >> Share

  161. CALCAGNO S, Di Pietro R, Biondi-Zoccai G, Versaci F, et al
    Cerebral protection device out of transcatheter heart procedures: a bridge to surgery.
    Eur Heart J. 2022;43:1598.
    >> Share

  162. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
    Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2022;43:1599.
    >> Share

    March 2022
  163. GALIUTO L, Massetti M
    To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
    Eur Heart J. 2022 Mar 10. pii: 6546148. doi: 10.1093.
    >> Share

  164. TRENKWALDER T, Krane M
    Mitral valve prolapse: will genetics finally solve the puzzle?
    Eur Heart J. 2022 Mar 10. pii: 6546010. doi: 10.1093.
    >> Share

  165. ROSELLI C, Yu M, Nauffal V, Georges A, et al
    Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.
    Eur Heart J. 2022 Mar 4. pii: 6542554. doi: 10.1093.
    >> Share

    February 2022
  166. KRALER S, Garg V, Akhmedov A
    Calcific aortic valve disease: novel insights into nitric oxide signalling.
    Eur Heart J. 2022 Feb 21. pii: 6533232. doi: 10.1093.
    >> Share

  167. RUDOLPH V
    Heart and kidney: towards an integrated approach to secondary mitral regurgitation.
    Eur Heart J. 2022 Feb 18. pii: 6530471. doi: 10.1093.
    >> Share


  168. Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thorac
    Eur Heart J. 2022 Feb 18. pii: 6533332. doi: 10.1093.
    >> Share

  169. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
    Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
    Eur Heart J. 2022 Feb 16. pii: 6531943. doi: 10.1093.
    >> Share

  170. SCHMIADY MO, Carrel T, Sigler M, Eildermann K, et al
    Transcatheter mitral valve in ring implantation: a word of caution based on histopathological workup.
    Eur Heart J. 2022 Feb 15. pii: 6528555. doi: 10.1093.
    >> Share

  171. CREA F
    A comprehensive update on valvular heart disease: from mechanisms to Guidelines.
    Eur Heart J. 2022;43:545-549.
    >> Share

  172. COLOMBO A, Maisano F
    A new tool for the forgotten valve: a score to predict the risk of surgery.
    Eur Heart J. 2022;43:663-665.
    >> Share

  173. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
    Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
    Eur Heart J. 2022;43:666-679.
    >> Share

  174. PAUL JF, Lansac E, Chambon E, Neuvillers L, et al
    Aortic jet lesion: new insights with multimodal imaging.
    Eur Heart J. 2022;43:543.
    >> Share

  175. LIU Z, Dong N, Hui H, Wang Y, et al
    Endothelial cell-derived tetrahydrobiopterin prevents aortic valve calcification.
    Eur Heart J. 2022 Feb 9. pii: 6525632. doi: 10.1093.
    >> Share

  176. IUNG B, Urena M
    New insights into transcatheter edge-to-edge repair: filling a gap for undertreatment of primary mitral regurgitation in the elderly?
    Eur Heart J. 2022;0.
    >> Share

  177. BEOHAR N, Ailawadi G, Kotinkaduwa LN, Redfors B, et al
    Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.
    Eur Heart J. 2022 Feb 3. pii: 6521532. doi: 10.1093.
    >> Share

    January 2022
  178. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
    Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
    Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
    >> Share

  179. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
    Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2022 Jan 28. pii: 6516865. doi: 10.1093.
    >> Share

  180. VOLPE M, Liuzzo G
    VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?
    Eur Heart J. 2022;43:181-182.
    >> Share

  181. BAUMGARTNER H, Iung B, Messika-Zeitoun D, Otto CM, et al
    The year in cardiovascular medicine 2021: valvular heart disease.
    Eur Heart J. 2022 Jan 3. pii: 6491394. doi: 10.1093.
    >> Share

    December 2021
  182. WEERASEKARE JM, Geske JB
    'Heart within a heart': echocardiographic assessment of hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:4775.
    >> Share

    November 2021
  183. BAUMGARTNER H
    Aortic stenosis management in 2021: better teaming up than fighting between specialties.
    Eur Heart J. 2021 Nov 28. pii: 6445126. doi: 10.1093.
    >> Share

  184. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
    Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
    Eur Heart J. 2021 Nov 25. pii: 6439994. doi: 10.1093.
    >> Share

  185. KRALER S, Blaser MC, Aikawa E, Camici GG, et al
    Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy.
    Eur Heart J. 2021 Nov 25. pii: 6440005. doi: 10.1093.
    >> Share

    October 2021
  186. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:3932-3944.
    >> Share

  187. ELLIOTT P
    Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative.
    Eur Heart J. 2021;42:3945-3947.
    >> Share

    September 2021
  188. DREYFUS J, Audureau E, Bohbot Y, Coisne A, et al
    TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.
    Eur Heart J. 2021 Sep 29. pii: 6377884. doi: 10.1093.
    >> Share

  189. CHEN QQ, Ma G, Liu JF, Cai YY, et al
    Neuraminidase 1 is a driver of experimental cardiac hypertrophy.
    Eur Heart J. 2021;42:3770-3782.
    >> Share

  190. RAMAKUMAR V, Gupta A, Goswami KC, Jagia P, et al
    Mitral valvular nodules of acute rheumatic fever masquerading as intracardiac mass.
    Eur Heart J. 2021 Sep 16. pii: 6371300. doi: 10.1093.
    >> Share

  191. VAHANIAN A, Praz F, Milojevic M, Beyersdorf F, et al
    The "ten commandments" for the 2021 ESC/EACTS Guidelines on valvular heart disease.
    Eur Heart J. 2021 Sep 16. pii: 6371303. doi: 10.1093.
    >> Share

  192. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
    >> Share

  193. MESSIKA-ZEITOUN D, Hibbert B, Chan V
    'Primary' percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime?
    Eur Heart J. 2021 Sep 2. pii: 6362540. doi: 10.1093.
    >> Share

    August 2021
  194. HABERMAN D, Estevez-Loureiro R, Benito-Gonzalez T, Denti P, et al
    Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
    Eur Heart J. 2021 Aug 31. pii: 6360026. doi: 10.1093.
    >> Share

  195. VAHANIAN A, Beyersdorf F, Praz F, Milojevic M, et al
    2021 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur Heart J. 2021 Aug 28. pii: 6358470. doi: 10.1093.
    >> Share

  196. LOPES LR, Garcia-Hernandez S, Lorenzini M, Futema M, et al
    Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:3063-3073.
    >> Share

  197. WALSH R, Bezzina CR
    ALPK3: a full spectrum cardiomyopathy gene?
    Eur Heart J. 2021;42:3074-3077.
    >> Share

  198. LAURI FM, Fernandez-Golfin C, Zamorano JL, Sanchez-Recalde A, et al
    Coronary compression caused by extrinsic adventitial damage: case of an early complication of trans-catheter tricuspid annuloplasty with cardioband device.
    Eur Heart J. 2021 Aug 18. pii: 6354189. doi: 10.1093.
    >> Share

  199. BRAUNWALD E
    Reflections on Hypertrophic Cardiomyopathy.
    Eur Heart J. 2021;42:2969-2970.
    >> Share

  200. TEN BERG J
    Antithrombotic therapy in patients undergoing trans catheter aortic valve implantation.
    Eur Heart J. 2021 Aug 9. pii: 6346754. doi: 10.1093.
    >> Share

  201. DANGAS G, Nicolas J, Mehran R
    Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data.
    Eur Heart J. 2021 Aug 9. pii: 6346755. doi: 10.1093.
    >> Share

  202. CREA F
    The new frontiers in valvular heart disease: from artificial intelligence to new pharmacological targets in aortic stenosis.
    Eur Heart J. 2021;42:2871-2875.
    >> Share

  203. GHAREBAGHI N, Mehdizade H, Askari B, Mirza-Aghazadeh-Attari M, et al
    A bizarre foreign object in the heart: toothpick lodged in the tricuspid valve.
    Eur Heart J. 2021;42:2957.
    >> Share

    July 2021
  204. TAMARGO J, Agewall S
    Fluoroquinolone use and valvular heart disease: is the jury still out?
    Eur Heart J. 2021 Jul 13. pii: 6319851. doi: 10.1093.
    >> Share

  205. STRANGE JE, Holt A, Blanche P, Gislason G, et al
    Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study.
    Eur Heart J. 2021 Jul 10. pii: 6318706. doi: 10.1093.
    >> Share

  206. OYETUNJI SO, Otto CM
    Transcatheter aortic valve implantation or replacement? Valve durability in the context of patient life expectancy.
    Eur Heart J. 2021 Jul 1. pii: 6311995. doi: 10.1093.
    >> Share

    June 2021
  207. ROGERS MA, Aikawa E
    Unbiased omics identifies mechanistic regulators of calcific aortic valve disease.
    Eur Heart J. 2021 Jun 28. pii: 6310290. doi: 10.1093.
    >> Share

  208. JORGENSEN TH, Thyregod HGH, Ihlemann N, Nissen H, et al
    Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.
    Eur Heart J. 2021 Jun 28. pii: 6310288. doi: 10.1093.
    >> Share

  209. WANG Y, Han D, Zhou T, Chen C, et al
    DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells.
    Eur Heart J. 2021 Jun 28. pii: 6310285. doi: 10.1093.
    >> Share

  210. XIE Y, Fang L, Li H, Xie M, et al
    Multimodality cardiac imaging for guidance of transapical transcatheter aortic valve implantation and mitral paravalvular leak closure.
    Eur Heart J. 2021 Jun 25. pii: 6309732. doi: 10.1093.
    >> Share

  211. MALAGOLI A, Chiusolo S, Tondi S
    Isolated double-orifice mitral valve: an atypical morphology in adult patient.
    Eur Heart J. 2021 Jun 21. pii: 6307143. doi: 10.1093.
    >> Share

  212. GOLIASCH G, Lang IM
    Impact of sex on the management and outcome of aortic stenosis patients: a female aortic valve stenosis paradox, and a call for personalized treatments?
    Eur Heart J. 2021 Jun 13. pii: 6297824. doi: 10.1093.
    >> Share

  213. VINNAKOTA S, Jentzer JC, Luis SA
    Thrombolysis for COVID-19-associated bioprosthetic mitral valve thrombosis with shock.
    Eur Heart J. 2021 Jun 11. pii: 6296967. doi: 10.1093.
    >> Share

  214. CREA F
    Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering.
    Eur Heart J. 2021;42:2137-2140.
    >> Share

    May 2021
  215. BIENJONETTI-BOUDREAU D, Fleury MA, Voisine M, Paquin A, et al
    Impact of sex on the management and outcome of aortic stenosis patients.
    Eur Heart J. 2021 May 23. pii: 6282426. doi: 10.1093.
    >> Share

  216. KASKI JP
    Childhood-onset hypertrophic cardiomyopathy research coming of age.
    Eur Heart J. 2021;42:1997-1999.
    >> Share

  217. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    >> Share

  218. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
    A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
    >> Share

  219. CALIGIURI G, Franck G
    Hitting the right channels to spread a 'no-restenosis' message to vascular wall cells.
    Eur Heart J. 2021;42:1786-1788.
    >> Share

    April 2021
  220. GENEREUX P, Piazza N, Alu MC, Nazif T, et al
    Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.
    Eur Heart J. 2021 Apr 19. pii: 6237954. doi: 10.1093.
    >> Share

  221. TEN BERG J, Sibbing D, Rocca B, Van Belle E, et al
    Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in coll
    Eur Heart J. 2021 Apr 5. pii: 6210683. doi: 10.1093.
    >> Share

    March 2021
  222. CREA F
    Challenges in heart failure: quality of life, chronic kidney disease, and secondary mitral regurgitation.
    Eur Heart J. 2021;42:1185-1189.
    >> Share

  223. COHEN-SHELLY M, Attia ZI, Friedman PA, Ito S, et al
    Electrocardiogram screening for aortic valve stenosis using artificial intelligence.
    Eur Heart J. 2021 Mar 22. pii: 6179522. doi: 10.1093.
    >> Share

  224. COATS AJS, Anker SD, Baumbach A, Alfieri O, et al
    The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and
    Eur Heart J. 2021 Mar 18. pii: 6174642. doi: 10.1093.
    >> Share

  225. DIBIE A, Landolff Q, Veugeois A, Amabile N, et al
    Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion.
    Eur Heart J. 2021;42:1051.
    >> Share

    February 2021
  226. CASE BC, Ben-Dor I, Satler LF, Waksman R, et al
    Rescue alcohol septal ablation for dynamic left ventricular outflow tract obstruction and haemodynamic collapse after transcatheter aortic valve implantation.
    Eur Heart J. 2021 Feb 21. pii: 6145857. doi: 10.1093.
    >> Share

  227. CREA F
    New guidelines on adult congenital heart disease, the fantastic four in the treatment of heart failure, and also what happened in the last year in heart failure and valvular heart disease.
    Eur Heart J. 2021;42:551-554.
    >> Share

  228. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
    Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
    >> Share

    January 2021
  229. KRONENBERG F
    Aortic valve stenosis: the long and winding road.
    Eur Heart J. 2021 Jan 31. pii: 6124840. doi: 10.1093/eurheartj/ehaa1069.
    >> Share

  230. QUERCIOLI A, Capettini AC, Gherli R, Secco GG, et al
    Three-dimensional echo guidance of percutaneous mitral paravalvular leak closure.
    Eur Heart J. 2021;42:359.
    >> Share

  231. GOPALAMURUGAN AB, Anantharaman R, Abubacker M, Varshaa GM, et al
    First-in-man proof of feasibility: PCI, TAVR, and TEVAR of aortic arch with a hybrid approach through a trans-caval (cavo-aortic) access in the same procedure.
    Eur Heart J. 2021;42:357.
    >> Share

  232. PEREZ DE ISLA L, Watts GF, Alonso R, Diaz-Diaz JL, et al
    Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Eur Heart J. 2021 Jan 12. pii: 6091158. doi: 10.1093/eurheartj/ehaa1066.
    >> Share

  233. GALIUTO L, Patrono C
    Rivaroxaban, a novel option for patients with atrial fibrillation and a bioprosthetic mitral valve.
    Eur Heart J. 2021 Jan 4. pii: 6062729. doi: 10.1093/eurheartj/ehaa1075.
    >> Share

  234. BERMEJO J, Postigo A, Baumgartner H
    The year in cardiovascular medicine 2020: valvular heart disease.
    Eur Heart J. 2021 Jan 3. pii: 6060050. doi: 10.1093/eurheartj/ehaa1060.
    >> Share

  235. NICHOLLS M
    The Year in Cardiovascular Medicine 2020: Valvular Heart Disease.
    Eur Heart J. 2021 Jan 3. pii: 6060073. doi: 10.1093/eurheartj/ehaa1024.
    >> Share

    December 2020
  236. QIAN H, Li Y, Qin Y, Huang H, et al
    An unusual left ventricle pseudo-aneurysm with progressive mitral regurgitation.
    Eur Heart J. 2020 Dec 31. pii: 6056658. doi: 10.1093/eurheartj/ehaa1076.
    >> Share

  237. CHEN J, Wei L, Wang C
    The impact of minimally invasive technique on the outcomes of isolated tricuspid valve surgery.
    Eur Heart J. 2020 Dec 12. pii: 6031686. doi: 10.1093.
    >> Share

  238. VERMEERSCH G, Prihadi E, De Keulenaer G, Vermeersch P, et al
    Giant native aortic valve thrombus under non-vitamin K antagonist oral anticoagulant: first manifestation of antiphospholipid syndrome.
    Eur Heart J. 2020 Dec 11. pii: 6030876. doi: 10.1093.
    >> Share

  239. AKAZAWA Y, Higaki T, Moritani T, Yamaguchi O, et al
    Acute mitral valve occlusion caused by atrial septal defect occluder.
    Eur Heart J. 2020 Dec 11. pii: 6031437. doi: 10.1093.
    >> Share

  240. CREA F
    Challenges in risk stratification of symptomatic and asymptomatic valvular heart disease: lessons from large observational studies.
    Eur Heart J. 2020;41:4289-4292.
    >> Share

  241. TOTH E, Dancy L, Amin-Youssef G, Papachristidis A, et al
    Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient.
    Eur Heart J. 2020;41:4365.
    >> Share

    November 2020
  242. HAHN RT
    Degenerative mitral stenosis: interpreting the meaning of mean gradient.
    Eur Heart J. 2020 Nov 30. pii: 6010480. doi: 10.1093.
    >> Share

  243. BERTRAND PB, Churchill TW, Yucel E, Namasivayam M, et al
    Prognostic importance of the transmitral pressure gradient in mitral annular calcification with associated mitral valve dysfunction.
    Eur Heart J. 2020 Nov 22. pii: 5998318. doi: 10.1093.
    >> Share

  244. SONG L, Jin J, Ma X, Xu M, et al
    Aortic dissection and rupture in a 3-year-old boy with bicuspid aortic valve.
    Eur Heart J. 2020 Nov 17. pii: 5986680. doi: 10.1093.
    >> Share

  245. REID A, Blanke P, Bax JJ, Leipsic J, et al
    Multimodality imaging in valvular heart disease: how to use state-of-the-art technology in daily practice.
    Eur Heart J. 2020 Nov 13. pii: 5981494. doi: 10.1093.
    >> Share

  246. WATANABE M, Miyachi H, Uchiyama S, Shimizu W, et al
    Thickening of the sinus of Valsalva wall and aortic valve leaflet in a case of Takayasu's arteritis.
    Eur Heart J. 2020 Nov 12. pii: 5979511. doi: 10.1093.
    >> Share

  247. ALIZADEHASL A, Salehi P, Roudbari S, Peighambari MM, et al
    Infectious endocarditis of the prosthetic mitral valve after COVID-19 infection.
    Eur Heart J. 2020 Nov 7. pii: 5960182. doi: 10.1093.
    >> Share

  248. GALIUTO L, Patrono C
    New hope for targeted treatment of obstructive hypertrophic cardiomyopathy: comment on the EXPLORER-HCM trial.
    Eur Heart J. 2020;41:4089-4090.
    >> Share

  249. SHARMA A, Bertog S, Mbai M
    Transcatheter aortic valve lithotripsy in severely calcified bicuspid aortic stenosis prior to transcatheter aortic valve implantation.
    Eur Heart J. 2020 Nov 6. pii: 5959818. doi: 10.1093.
    >> Share

    October 2020
  250. IDRIS A, Smith Ii RL, Ryan WH, Wang Z, et al
    Primary malignant fibrous histiocytoma of the mitral valve as a rare incidental finding.
    Eur Heart J. 2020 Oct 17. pii: 5927542. doi: 10.1093.
    >> Share

  251. SWEDA R, Berger D, Heverhagen JT, Hunziker L, et al
    Pulmonary haemorrhage on veno-arterial ECMO: consequences of missed aortic valve regurgitation.
    Eur Heart J. 2020 Oct 14. pii: 5922864. doi: 10.1093.
    >> Share

    September 2020
  252. DELGADO V, Ajmone Marsan N, Bax JJ
    The difficult decision of when and in whom to perform isolated tricuspid valve surgery.
    Eur Heart J. 2020 Sep 27. pii: 5912178. doi: 10.1093.
    >> Share

  253. VALLABHAJOSYULA S, Said SM, Kitzmann AS, Michelena HI, et al
    Accelerated extensive mitral valve calcification in a young end-stage kidney disease patient.
    Eur Heart J. 2020 Sep 27. pii: 5912177. doi: 10.1093.
    >> Share

  254. GARBI M, Lancellotti P
    Heart Valve Specialist Core Syllabus of the ESC Council on Valvular Heart Disease.
    Eur Heart J. 2020 Sep 25. pii: 5911420. doi: 10.1093.
    >> Share

  255. DREYFUS J, Flagiello M, Bazire B, Eggenspieler F, et al
    Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes.
    Eur Heart J. 2020 Sep 25. pii: 5911419. doi: 10.1093.
    >> Share

    August 2020
  256. LUSCHER TF
    Frontiers in valvular heart disease: outcomes of novel percutaneous procedures.
    Eur Heart J. 2020;41:2717-2720.
    >> Share

    May 2020
  257. LUSCHER TF
    From TAVI to tricuspid cliping: fine-tuning the management of valvular heart disease.
    Eur Heart J. 2020;41:1863-1866.
    >> Share

  258. NAZARZADEH M, Rahimi K
    Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects.
    Eur Heart J. 2020;41:1942.
    >> Share

  259. NICKENIG G, Vogelhuber J
    The tricuspid tragedy: from Cinderella to celebrity.
    Eur Heart J. 2020;41:1930-1931.
    >> Share

  260. WEBB J, Wood D, Sathananthan J, Landes U, et al
    Balloon-expandable or self-expandable transcatheter heart valves. Which are best?
    Eur Heart J. 2020;41:1900-1902.
    >> Share

    February 2020
  261. JERING KS, Pfeffer MA
    From practice changing to hypothesis generating: a virtuous cycle.
    Eur Heart J. 2020;41:955-957.
    >> Share

  262. LUSCHER TF
    Valvular heart disease: improved procedural success and prediction of outcomes.
    Eur Heart J. 2020;41:899-902.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016